Boden et al. (1) reported that insulin-induced endoplasmic reticulum (ER) stress increased in subcutaneous adipose tissue of human subjects in vivo. The authors elegantly show that the induction of the unfolded protein response was not related to increased glucose metabolism or oxidative stress. The response was, however, associated with accumulation of ubiquitination-associated proteins, some of which are potential causes for ER stress. From these data, the authors conclude that they revealed a putative mechanism for the development of ER stress in obesity. Whether or not the activating effect of insulin on ER stress will become resistant in the setting of obesity-associated insulin resistance was not addressed.
We have previously shown insulin-induced markers of ER stress in primary mouse hepatocytes. The effect was completely prevented by the inhibition of phosphatidylinositide 3 (PI3) kinase (2). Therefore, we addressed the question of whether or not the activating effect of insulin on ER stress is abrogated in the setting of insulin resistance. Mice were studied in vivo after a 3-day high-fat diet, a dietary challenge that results in hepatic lipid accumulation and hepatic insulin resistance (3–5). In this setting, insulin still increased hepatic Grp78 protein expression as well as X-box binding protein 1 (XBP1s) and C/EBP homologous protein (CHOP) mRNA expression, while other functions of insulin, such as suppression of hepatic glucose output, were decreased (2,6). Moreover, in mice functionally lacking the eIF2α-mediated branch of the unfolded protein response (7), the increase in XBP1s and CHOP by insulin was further enhanced, demonstrating that the eIF2α-mediated arm of the unfolded protein response is needed to properly resolve insulin-mediated ER stress (2,8). It would be important to understand whether or not insulin-resistant humans also remain sensitive to insulin-induced ER stress.
Funding. S.L. and A.L.B. are supported by a research grant from the German Research Foundation (BI1292/4-1).
Duality of Interest. No potential conflicts of interest relevant to this article were reported.
- © 2014 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.